Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9659 +0.0166 (+1.75%)
Streaming Delayed Price Updated: 2:59 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ocugen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Peering Into Ocugen's Recent Short Interest
Via Benzinga
Ocugen (OCGN) Q2 2024 Earnings Call Transcript
OCGN earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Ocugen (OCGN) Stock Is Falling
Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering. 
Via Benzinga
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
These two stocks could have vastly different long-term performances. 
Via The Motley Fool
3 Penny Stocks That Could Turn $10K Into $100K in 3 Years
Discover three high-potential penny stocks that could derive 10X returns in biotechnology, silver and oil and gas storage and transportation. 
Via InvestorPlace
7 A-Rated Penny Stocks to Beat June Gloom
Some penny stocks can be diamonds in the rough. These A-rated penny stocks are all solid picks for a portfolio this month. 
Via InvestorPlace
(OCGN) - Analyzing Ocugen's Short Interest
Via Benzinga
4 Analysts Assess Ocugen: What You Need To Know
Via Benzinga
OCGN Stock Earnings: Ocugen Beats EPS for Q1 2024
OCGN stock results show that Ocugen beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Penny Stocks Set to Make New Millionaires in 2024
Explore the best penny stocks to buy and their progressive fundamentals in biotechnology, healthcare, and electrical components. 
Via InvestorPlace
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
7 A-Rated Biotech Stocks Worth Betting on in June
A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation. 
Via InvestorPlace
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole
Don't jump on the bandwaggon. 
Via The Motley Fool
DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Key Takeaways From Ocugen Analyst Ratings
Via Benzinga
OCGN Stock Earnings: Ocugen Beats EPS for Q4 2023
OCGN stock results show that Ocugen beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
OCGN Stock Alert: Why Is Ocugen Up 20% Today?
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications. 
Via InvestorPlace
Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Millionaire Blueprint: 3 Stocks Under $5 With Massive Growth Potential by 2028
Discover high-potential penny stocks set to skyrocket, offering savvy investors exciting growth opportunities. 
Via InvestorPlace
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Can Ocugen Stock Keep Churning Higher?
This tiny biotech caught fire in 2024. Can it sustain the momentum? 
Via The Motley Fool
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why Is Auddia (AUUD) Stock Up 192% Today?
Auddia stock is taking off on Monday with heavy trading of AUUD stock after the company received a new AI tech patent. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Ocugen Shares Are Trading Higher
Ocugen shares are trading higher by 7.7% during Monday's session. The company announced U.S. FDA clearance of the IND amendment to initiate a Phase 3 clinical trial of OCU400. 
Via Benzinga
Exposures Product Safety
Why Is Ocugen (OCGN) Stock Up 7% Today?
Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results. 
Via InvestorPlace
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Ocugen Shares Are Popping Off
Ocugen shares are trading higher by 14% during Wednesday's session. The company provided an update on its business activities and financial status for 2023. 
Via Benzinga
Why Ocugen Stock Is Climbing Today
Ocugen shares are trading higher Friday after the company announced it has received approval to proceed dosing with the medium dose of OCU410 in the dose-escalation phase of its Phase 1/2 study. Ocugen... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.